Clinical Trial Detail

NCT ID NCT03120832
Title Phase 1 Trial of PAN-301-1 in Cancer Patients
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors Panacea Pharmaceuticals, Inc.
Indications

prostate cancer

Therapies

PAN-301-1

Age Groups: adult senior

No variant requirements are available.